Seer, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Seer, Inc. (SEER) is 71.38M

According to Seer, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.38M. This represents a change of -21.55% compared to the average of 90.99M of the last 4 quarters.

Seer, Inc. (SEER) Historical Enterprise Value (quarterly & annually)

How has SEER Enterprise Value performed in the past?

The mean historical Enterprise Value of Seer, Inc. over the last ten years is 1.19B. The current 71.38M Enterprise Value has changed 498.82% with respect to the historical average. Over the past ten years (40 quarters), SEER's Enterprise Value was at its highest in in the September 2020 quarter at 3.28B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Seer, Inc. (SEER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Seer, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seer, Inc. (SEER) Average Enterprise Value

How has SEER Enterprise Value performed in the past?

The current Enterprise Value of Seer, Inc. (SEER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seer, Inc. (SEER) Enterprise Value vs. Peers

How is SEER’s Enterprise Value compared to its peers?

Seer, Inc.’s Enterprise Value is less than ORIC Pharmaceuticals, Inc. (825.76M), greater than Anebulo Pharmaceuticals, Inc. (6.86M), less than Cullinan Therapeutics, Inc. (851.02M), less than C4 Therapeutics, Inc. (340.91M), greater than Molecular Partners AG (40.49M), less than Mineralys Therapeutics, Inc. (1.52B), less than AN2 Therapeutics, Inc. (83.52M), less than Pharvaris N.V. (1.75B), less than PepGen Inc. (98.22M), less than Foghorn Therapeutics Inc. (196.74M), less than Shattuck Labs, Inc. (149.59M), less than Monte Rosa Therapeutics, Inc. (1.07B), less than Kymera Therapeutics, Inc. (7.37B), less than Nurix Therapeutics, Inc. (1.51B), less than Quantum-Si incorporated (165.14M), greater than HCW Biologics Inc. (7.62M), greater than MediciNova, Inc. (37.81M), less than Nkarta, Inc. (252.26M), less than Lyell Immunopharma, Inc. (255.36M), greater than Generation Bio Co. (40.14M), less than Sana Biotechnology, Inc. (868.15M),

Build a custom stock screener for Seer, Inc. (SEER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seer, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seer, Inc. (SEER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seer, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.